Amylyx Pharmaceuticals (AMLX) News Today $9.42 -0.03 (-0.32%) Closing price 04:00 PM EasternExtended Trading$9.48 +0.06 (+0.69%) As of 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMLX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Amylyx Pharmaceuticals, Inc. $AMLX Shares Acquired by Alpha Wave Global LPAugust 28 at 8:37 AM | marketbeat.com57,133 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Purchased by Algert Global LLCAugust 28 at 4:21 AM | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Consensus Rating of "Buy" by BrokeragesAugust 28 at 2:25 AM | americanbankingnews.comAmylyx to stop development of rare brain disorder drug after trial failureAugust 27 at 11:54 PM | reuters.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Trading Down 5.9% - Should You Sell?August 27 at 3:07 PM | marketbeat.comAmylyx Pharmaceuticals Advances Phase 3 Study on Avexitide for Post-Bariatric HypoglycemiaAugust 22, 2025 | msn.comAberdeen Group plc Has $8.60 Million Stock Position in Amylyx Pharmaceuticals, Inc. $AMLXAugust 22, 2025 | marketbeat.comH.C. Wainwright, Leerink Partners, and TD Cowen Reaffirm ‘Buy’ Ratings on Amylyx Pharmaceuticals, Inc. (AMLX)August 19, 2025 | insidermonkey.comConnor Clark & Lunn Investment Management Ltd. Has $4.25 Million Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)August 15, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Amylyx Pharmaceuticals Inc (AMLX) and Cormedix (CRMD)August 14, 2025 | theglobeandmail.comAmylyx Pharmaceuticals’ Promising Earnings Call HighlightsAugust 13, 2025 | msn.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Announces Earnings ResultsAugust 11, 2025 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | msn.comAmylyx Pharmaceuticals: Progress in Trials and FinancialsAugust 8, 2025 | tipranks.comAmylyx Pharmaceuticals Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | finance.yahoo.comAmylyx Pharmaceuticals Advances ALS Treatment with AMX0114 Clinical TrialAugust 7, 2025 | msn.comAmylyx Pharmaceuticals, Inc. (AMLX) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comAmylyx Pharmaceuticals Q2 2025 Earnings PreviewAugust 7, 2025 | msn.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Consensus Recommendation of "Buy" from AnalystsAugust 3, 2025 | marketbeat.comAmylyx Pharmaceuticals (AMLX) to Release Earnings on ThursdayAugust 2, 2025 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Bought by Kennondale Capital Management LLCJuly 22, 2025 | marketbeat.comAmylyx Pharmaceuticals: A High-Risk Pipeline With Strong Upside PotentialJuly 21, 2025 | seekingalpha.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 1-Year High - Time to Buy?July 21, 2025 | marketbeat.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded at Wall Street ZenJuly 19, 2025 | marketbeat.comAmylyx Pharmaceuticals Shares Promising Avexitide Data for Post-Bariatric Hypoglycemia at ENDO 2025, Phase 3 Enrollment Nears CompletionJuly 15, 2025 | finance.yahoo.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 52-Week High - Still a Buy?July 15, 2025 | marketbeat.comAmylyx presents new exploratory analyses from avexitide trials for PBHJuly 15, 2025 | finance.yahoo.comAMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJuly 14, 2025 | globenewswire.comAmylyx Drug Slashes Sugar Spikes Post-Weight Loss SurgeryJuly 14, 2025 | benzinga.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Shares Gap Up - Here's WhyJuly 14, 2025 | marketbeat.comAmylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025July 13, 2025 | businesswire.comThe Goldman Sachs Group Begins Coverage on Amylyx Pharmaceuticals (NASDAQ:AMLX)July 10, 2025 | marketbeat.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 52-Week High - Here's What HappenedJuly 9, 2025 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Rating of "Moderate Buy" from BrokeragesJuly 9, 2025 | marketbeat.comAMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJuly 7, 2025 | globenewswire.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 4.8% - Should You Buy?July 7, 2025 | marketbeat.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Trading Down 8.4% - Time to Sell?July 3, 2025 | marketbeat.comAMLX - Amylyx Pharmaceuticals Inc Dividends - MorningstarJune 28, 2025 | morningstar.comMAmylyx Pharmaceuticals Inc News (AMLX) - Investing.comJune 28, 2025 | investing.comWhy Shares in Amylyx Pharmaceuticals Soared This WeekJune 27, 2025 | msn.comAMLX Amylyx Pharmaceuticals, Inc. - Seeking AlphaJune 27, 2025 | seekingalpha.comAmylyx Pharma (NASDAQ:AMLX) Stock, Insider Trading ActivityJune 25, 2025 | benzinga.com13 Best Biotech Stocks To Invest In NowJune 24, 2025 | insidermonkey.comGuggenheim Initiates Coverage of Amylyx Pharmaceuticals (AMLX) with Buy RecommendationJune 24, 2025 | msn.comAmylyx Pharmaceuticals Gains FDA Fast Track for ALS Drug AMX0114June 24, 2025 | msn.comAmylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash MarketJune 24, 2025 | benzinga.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Shares Gap Up - What's Next?June 24, 2025 | marketbeat.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Now Covered by GuggenheimJune 24, 2025 | marketbeat.comAmylyx Pharmaceuticals (NASDAQ:AMLX) Coverage Initiated by Analysts at CitigroupJune 17, 2025 | marketbeat.comAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Recommendation of "Buy" by BrokeragesJune 14, 2025 | marketbeat.com Get Amylyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMLX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMLX Media Mentions By Week AMLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMLX News Sentiment▼0.881.03▲Average Medical News Sentiment AMLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMLX Articles This Week▼94▲AMLX Articles Average Week Get the Latest News and Ratings for AMLX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Arrowhead Pharmaceuticals News Today NewAmsterdam Pharma News Today Immunovant News Today Recursion Pharmaceuticals News Today Catalyst Pharmaceuticals News Today Kiniksa Pharmaceuticals International News Today Organon & Co. News Today Alvotech News Today Centessa Pharmaceuticals News Today ImmunityBio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMLX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access